Robert Kay
CIK 1285612 · View on SEC EDGAR ↗
First SEC filing: Aug. 12, 2008 · Latest: Aug. 12, 2008
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 12, 2020 | IBIO | A | 400,000 | — | — | 400,000 Direct | — | Acquired | (price as of 2026-08-19) |
| June 12, 2020 | IBIO | A | 400,000 | — | — | 400,000 Direct | — | Acquired | (price as of 2026-08-19) |
| July 15, 2013 | IBIO | A | 300,000 | — | — | 300,000 Direct | — | Acquired | (price as of 2026-08-19) |
| July 24, 2012 | IBIO | A | 300,000 | — | — | 300,000 Direct | — | Acquired | (price as of 2026-08-19) |
| Oct. 21, 2011 | IBIO | A | 300,000 | — | — | 300,000 Direct | — | Acquired | (price as of 2026-08-19) |
| Dec. 30, 2010 | IBIO | A | 1,000,000 | — | — | 1,000,000 Direct | — | Acquired | (price as of 2026-08-19) |
| Aug. 16, 2010 | IBIO | A | 300,000 | — | — | 300,000 Direct | — | Acquired | (price as of 2026-08-19) |
| Aug. 10, 2009 | IBIO | A | 250,000 | — | — | 250,000 Direct | — | Acquired | (price as of 2026-08-19) |
| Feb. 13, 2009 | IBIO | A | 250,000 | — | — | 250,000 Direct | — | Acquired | (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 12, 2020 | IBIO | Stock Option | Common Stock (400,000) | — | June 12, 2030 | 400,000 | Acquired |
| June 12, 2020 | IBIO | Stock Option | Common Stock (400,000) | $1.40 | June 12, 2030 | 400,000 | Acquired |
| July 15, 2013 | IBIO | Stock Option (right to buy) | Common Stock (300,000) | $0.52 | July 15, 2023 | 300,000 | Acquired |
| July 24, 2012 | IBIO | Stock Option (right to buy) | Common Stock (300,000) | $1.10 | July 24, 2022 | 300,000 | Acquired |
| Oct. 21, 2011 | IBIO | Stock Option (right to buy) | Common Stock (300,000) | $1.96 | Oct. 21, 2021 | 300,000 | Acquired |
| Dec. 30, 2010 | IBIO | Stock Option (right to buy) | Common Stock (1,000,000) | $3.07 | Dec. 30, 2020 | 1,000,000 | Acquired |
| Aug. 16, 2010 | IBIO | Stock Option (right to buy) | Common Stock (300,000) | $1.73 | Aug. 16, 2020 | 300,000 | Acquired |
| Aug. 10, 2009 | IBIO | Stock Option (right to buy) | Common Stock (250,000) | $0.66 | Aug. 10, 2019 | 250,000 | Acquired |
| Feb. 13, 2009 | IBIO | Stock Option (right to buy) | Common Stock (250,000) | $0.20 | Feb. 13, 2019 | 250,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 12, 2008 | IBIO | Common Stock | 1,030,962 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $283,035 | — | — | $583,935 | — | — | $41,652 | $908,622 |
| 2017 | $310,732 | — | — | $107,085 | — | — | — | $417,817 |
| 2016 | $310,732 | — | — | $470,495 | — | — | — | $781,227 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.